Segura S et al. |
Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream. |
2005 |
Acta Derm. Venereol. |
pmid:16396803
|
Mercader P et al. |
Treatment of protein contact dermatitis with topical tacrolimus. |
2005 |
Acta Derm. Venereol. |
pmid:16396818
|
Pagliarello C and Paradisi A |
Topical tacrolimus is useful for avoiding suction-blister epidermal grafting depigmentation in non-segmental vitiligo: a case report. |
2012 |
Acta Derm. Venereol. |
pmid:22101735
|
Mandelin J et al. |
Leg ulcers treated with topical tacrolimus in patients with rheumatoid arthritis. |
2010 |
Acta Derm. Venereol. |
pmid:21057750
|
Honda Y et al. |
Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions. |
2015 |
Acta Derm. Venereol. |
pmid:25881714
|
Pitarch G et al. |
Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. |
2006 |
Acta Derm. Venereol. |
pmid:16585995
|
Cunha PR |
Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids. |
2006 |
Acta Derm. Venereol. |
pmid:16585998
|
Cunha PR and Rossi AB |
Pimecrolimus cream 1% is effective in a case of granulomatous rosacea. |
2006 |
Acta Derm. Venereol. |
pmid:16585999
|
De Rie MA et al. |
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. |
1996 |
Acta Derm. Venereol. |
pmid:8891007
|
Kim TW et al. |
Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial. |
2013 |
Acta Derm. Venereol. |
pmid:23388687
|